Marko Geber/DigitalVision via Getty Images Investment Overview – Can Biogen/Eisai’s Success With Lecanemab Be Matched By Anavex’s Lead Candidate? Anavex Life Sciences (NASDAQ:AVXL) stock has underperformed in 2022, falling in value by ~48% to trade […]
Douglas Rissing By Kevin Flanagan With one month to go in 2022, investors are no doubt eager to see what 2023 will hold. The Fed’s highwire act of fighting inflation while avoiding recession will certainly […]
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.